Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01869114
Title Sirolimus and Azacitidine in Treating Patients With High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia That is Recurrent or Not Eligible for Intensive Chemotherapy
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Thomas Jefferson University
Indications

acute myeloid leukemia

bone marrow cancer

Therapies

Azacitidine + Sirolimus

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Jefferson Health NJ Division (Kennedy Hospital) Sewell New Jersey 08012 United States Details
Abington Hospital - Jefferson Health Abington Pennsylvania 19001 United States Details
Sidney Kimmel Cancer Center at Thomas Jefferson University Philadelphia Pennsylvania 19107 United States Details
Jefferson Health, Aria Hospital Philadelphia Pennsylvania 19124 United States Details
Jefferson Health, Methodist Hospital Philadelphia Pennsylvania 19148 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field